Terebyo

Terebyo (teriflunomide) is an oral medication used to manage certain autoimmune conditions. It belongs to the immunomodulatory class, supporting disease modification in relapsing forms of multiple sclerosis. This non-interferon therapy offers an alternative for patients seeking broad symptom control.

Terebyo is prescribed to reduce the frequency of relapses and delay physical disability progression in adults with relapsing-remitting multiple sclerosis. It is also used to treat rheumatoid arthritis by modulating immune response and reducing inflammation. Patients often ask, 'what is teriflunomide used for' when exploring treatment options for autoimmune disorders.

Common effects of Terebyo include mild gastrointestinal discomfort, headache, and hair thinning. Some users report fatigue or mild nausea, particularly when starting therapy. These effects are typically temporary and may diminish with continued use.

Terebyo should be taken exactly as prescribed, with regular monitoring for liver function and blood cell counts. Patients with liver disease or severe infections should discuss risks with their healthcare provider before use. Avoid alcohol while taking this medication to reduce potential liver strain.

Terebyo may interact with drugs that affect liver enzymes, such as certain antibiotics or antiepileptics. Combining it with immunosuppressants or live vaccines could increase infection risk. Always inform your doctor about all medications, including over-the-counter and herbal products, before starting Terebyo.